1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

13 Oct 2023
Admin
News Article

Fujitsu and RIKEN Develop AI Technology for Predicting Protein Structural Changes

Fujitsu and RIKEN have jointly unveiled an AI-driven drug discovery technology capable of predicting structural changes in proteins using generative AI technology, which converts electron microscope images into 3D density maps.

Fujitsu and RIKEN will integrate their newly developed generative AI technology as a core component of the next-generation IT-based drug discovery system. This system aims to unravel the intricate connections between target proteins and antibodies, offering a high-speed and highly accurate prediction of wide-ranging structural changes in molecules.

This technology enables the precise determination of protein conformations and changes, using experimental data in a fraction of the time typically required by conventional methods. This breakthrough promises to revolutionise the drug design process, particularly for creating drugs that target proteins associated with bacteria and viruses.

The generative AI technology, developed by Fujitsu and RIKEN, accurately estimates the various conformations of a target protein and their potential proportions from a multitude of electron microscopy projection images. Additionally, it predicts changes in the target protein's conformation based on these estimated proportions.

Together, these two technologies form an AI-driven drug discovery system that can forecast structural protein alterations on a broad scale, with the overarching goal of significantly reducing the time and cost involved in drug discovery processes.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!